Expression of antigen processing and presenting molecules by Schwann cells in inflammatory neuropathies

GLIA

Volumn 58, Issue 1, 2010, Pages 80-92

  Meyer Zu Horste, Gerd ^a   Heidenreich, Holger ^a   Lehmann, Helmar C ^a   Ferrone, Soldano ^b   Hartung, Hans Peter ^a   Wiendl, Heinz ^c   Kieseier, Bernd C ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

^b UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^c UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Antigen presentation; Guillain Barr syndrome; Inflammatory neuropathy; Schwann cell

Indexed keywords

CALNEXIN; CALRETICULIN; CYTOKINE; OVALBUMIN; PROTEIN P75; PROTEIN S 100;

ANTIGEN EXPRESSION; ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CELL INTERACTION; CELL VIABILITY; CONTROLLED STUDY; FLOW CYTOMETRY; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; IN VITRO STUDY; IN VIVO STUDY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCHWANN CELL;

ANTIGEN PRESENTATION; ANTIGEN-PRESENTING CELLS; ATP-BINDING CASSETTE TRANSPORTERS; CELLS, CULTURED; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GLIAL FIBRILLARY ACIDIC PROTEIN; GUILLAIN-BARRE SYNDROME; HISTOCOMPATIBILITY ANTIGENS CLASS I; HLA ANTIGENS; HUMANS; INFANT, NEWBORN; INTERFERON-ALPHA; OVALBUMIN; PROTEASOME ENDOPEPTIDASE COMPLEX; RECEPTOR, NERVE GROWTH FACTOR; S100 PROTEINS; SCHWANN CELLS; SURAL NERVE; TIME FACTORS;

EID: 72749126898     PISSN: 08941491     EISSN: 10981136     Source Type: Journal    
DOI: 10.1002/glia.20903     Document Type: Article

References (61)

1. Ackerman AL, Cresswell P. 2004. Cellular mechanisms governing crosspresentation of exogenous antigens. Nat Immunol 5:678- 684.
2. Ansselin AD, Pollard JD. 1990. Immunopathological factors in peripheral nerve allograft rejection: Quantification of lymphocyte invasion and major histocompatibility complex expression. J Neurol Sci 96:75 - 88.
3. Argall KG, Armati PJ, King NJ, Douglas MW. 1991. The effects of West Nile virus on major histocompatibility complex Class I, II molecule expression by Lewis rat Schwann cells in vitro. J Neuroimmunol 35:273 - 284.
4. Argall KG, Armati PJ, Pollard JD, Bonner J. 1992a. Interactions between CD4+ T-cells and rat Schwann cells in vitro. 2. Cytotoxic effects of P2-specific CD4+ T-cell lines on Lewis rat Schwann cells. J Neuroimmunol 40:19 - 29.
5. Argall KG, Armati PJ, Pollard JD, Watson E, Bonner J. 1992b. Interactions between CD4+ T-cells and rat Schwann cells in vitro. 1. Antigen presentation by Lewis rat Schwann cells to P2-specific CD4+ T-cell lines. J Neuroimmunol 40:1 - 18.
6. Armati PJ, Pollard JD, Gatenby P. 1990. Rat and human Schwann cells in vitro can synthesize and express MHC molecules. Muscle Nerve 13:106 - 116.
7. Asbury AK, Cornblath DR. 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27 (Suppl):S21 - S24.
8. Bandoh N, Ogino T, Cho HS, Hur SY, Shen J, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S. 2005. Development and characterization of human constitutive proteasome and immunoproteasome subunit-specific monoclonal antibodies. Tissue Antigens 66:185 - 194.
9. Bergsteinsdottir K, Kingston A, Jessen KR. 1992. Rat Schwann cells can be induced to express major histocompatibility complex Class II molecules in vivo. J Neurocytol 21:382 - 390.
10. Bottazzo GF, Pujol-Borrell R, Hanafusa T, Feldmann M. 1983. Role of aberrant HLA-DR expression and antigen presentation in induction of endocrine autoimmunity. Lancet 2:1115 - 1119.
11. Casella GT, Bunge RP, Wood PM. 1996. Improved method for harvesting human Schwann cells from mature peripheral nerve and expansion in vitro. Glia 17:327 - 338.
12. Choi J, Enis DR, Koh KP, Shiao SL, Pober JS. 2004. T lymphocyteendothelial cell interactions. Annu Rev Immunol 22:683 - 709.
13. Cornblath DR, Griffin DE, Welch D, Griffin JW, McArthur JC. 1990. Quantitative analysis of endoneurial T-cells in human sural nerve biopsies. J Neuroimmunol 26:113 - 118.
14. Dani A, Chaudhry A, Mukherjee P, Rajagopal D, Bhatia S, George A, Bal V, Rath S, Mayor S. 2004. The pathway for MHCII-mediated presentation of endogenous proteins involves peptide transport to the endo-lysosomal compartment. J Cell Sci 117 (Part 18): 4219 - 4230.
15. Duan RS, Jin T, Yang X, Mix E, Adem A, Zhu J. 2007. Apolipoprotein E deficiency enhances the antigen-presenting capacity of Schwann cells. Glia 55:772 - 776.
16. Ford AL, Britton WJ, Armati PJ. 1993. Schwann cells are able to present exogenous mycobacterial hsp70 to antigen-specific T lymphocytes. J Neuroimmunol 43:151 - 159.
17. Fujioka T, Purev E, Kremlev SG, Ventura ES, Rostami A. 2000. Flow cytometric analysis of infiltrating cells in the peripheral nerves in experimental allergic neuritis. J Neuroimmunol 108:181 - 191.
18. Gold R, Toyka KV, Hartung HP. 1995. Synergistic effect of IFN-gamma and TNF-alpha on expression of immune molecules and antigen presentation by Schwann cells. Cell Immunol 165:65 - 70.
19. Griffin JW, Sheikh K. 2005. The Guillain-Barré syndromes. In: Dyck PJ, Thomas PK, editors. Peripheral neuropathy. Philadelphia: Elsevier Saunders. pp 2197 - 2220.
20. Hu W, Mathey E, Hartung HP, Kieseier BC. 2003. Cyclo-oxygenases and prostaglandins in acute inflammatory demyelination of the peripheral nerve. Neurology 61:1774 - 1779.
21. Hughes RA, Cornblath DR. 2005. Guillain-Barre syndrome. Lancet 366:1653 - 1666.
22. Kiefer R, Kieseier BC, Bruck W, Hartung HP, Toyka KV. 1998. Macrophage differentiation antigens in acute and chronic autoimmune polyneuropathies. Brain 121:469 - 479.
23. Kiefer R, Dangond F, Mueller M, Toyka KV, Hafler DA, Hartung HP. 2000. Enhanced B7 costimulatory molecule expression in inflammatory human sural nerve biopsies. J Neurol Neurosurg Psychiatry 69:362 - 368.
24. Kieseier BC, Kiefer R, Gold R, Hemmer B, Willison HJ, Hartung HP. 2004. Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system. Muscle Nerve 30:131 - 156.
25. Kingston AE, Bergsteinsdottir K, Jessen KR, Van der Meide PH, Colston MJ, Mirsky R. 1989. Schwann cells co-cultured with stimulated T cells and antigen express major histocompatibility complex (MHC) Class II determinants without interferon-gamma pretreatment: Synergistic effects of interferon-gamma and tumor necrosis factor on MHC Class II induction. Eur J Immunol 19: 177 - 183.
26. Lilje O. 2002. The processing and presentation of endogenous and exogenous antigen by Schwann cells in vitro. Cell Mol Life Sci 59: 2191 - 2198.
27. Lilje O, Armati PJ. 1997. The distribution and abundance of MHC, ICAM-1 on Schwann cells in vitro. J Neuroimmunol 77:75 - 84.
28. Lisak RP, Bealmear B. 1992. Differences in the capacity of gammainterferons from different species to induce Class I, II major histocompatibility complex antigens on neonatal rat Schwann cells in vitro. Pathobiology 60:322 - 329.
29. Malnati MS, Marti M, LaVaute T, Jaraquemada D, Biddison W, DeMars R, Long EO. 1992. Processing pathways for presentation of cytosolic antigen to MHC Class II-restricted T cells. Nature 357:702 - 704.
30. Mancardi GL, Cadoni A, Zicca A, Schenone A, Tabaton M, De Martini I, Zaccheo D. 1988. HLA-DR Schwann cell reactivity in peripheral neuropathies of different origins. Neurology 38:848 - 851.
31. Matkowskyj KA, Schonfeld D, Benya RV. 2000. Quantitative immunohistochemistry by measuring cumulative signal strength using commercially available software photoshop and matlab. J Histochem Cytochem 48:303 - 312.
32. Matkowskyj KA, Cox R, Jensen RT, Benya RV. 2003. Quantitative immunohistochemistry by measuring cumulative signal strength accurately measures receptor number. J Histochem Cytochem 51:205 - 214.
33. Mehling M, Simon P, Mittelbronn M, Meyermann R, Ferrone S, Weller M, Wiendl H. 2007. WHO grade associated downregulation of MHC Class I antigen-processing machinery components in human astrocytomas: Does it reflect a potential immune escape mechanism? Acta Neuropathol 114:111 - 119.
34. Meyer zu Horste G, Hartung HP, Kieseier BC. 2007. From bench to bedside - Experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat Clin Pract Neurol 3:198 - 211.
35. Meyer zu Horste G, Hu W, Hartung HP, Lehmann HC, Kieseier BC. 2008. The immunocompetence of Schwann cells. Muscle Nerve 37:3 - 13.
36. Mitchell GW, Williams GS, Bosch EP, Hart MN. 1991. Class II antigen expression in peripheral neuropathies. J Neurol Sci 102: 170 - 176.
37. Muller M, Stenner M, Wacker K, Ringelstein EB, Hickey WF, Kiefer R. 2006. Contribution of resident endoneurial macrophages to the local cellular response in experimental autoimmune neuritis. J Neuropathol Exp Neurol 65:499 - 507.
38. Murata K, Dalakas MC. 2000. Expression of the co-stimulatory molecule BB-1, the ligands CTLA-4 and CD28 and their mRNAs in chronic inflammatory demyelinating polyneuropathy. Brain 123:1660 - 1666.
39. Odink K, Cerletti N, Bruggen J, Clerc RG, Tarcsay L, Zwadlo G, Gerhards G, Schlegel R, Sorg C. 1987. Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis. Nature 330:80 - 82.
40. Ogino T, Wang X, Kato S, Miyokawa N, Harabuchi Y, Ferrone S. 2003. Endoplasmic reticulum chaperone-specific monoclonal antibodies for flow cytometry and immunohistochemical staining. Tissue Antigens 62:385 - 393.
41. Pfeifer JD, Wick MJ, Roberts RL, Findlay K, Normark SJ, Harding CV. 1993. Phagocytic processing of bacterial antigens for Class I MHC presentation to T cells. Nature 361:359 - 362.
42. Pollard JD, Baverstock J, McLeod JG. 1987. Class II antigen expression and inflammatory cells in the Guillain-Barre syndrome. Ann Neurol 21:337 - 341.
43. Rutkowski JL, Kirk CJ, Lerner MA, Tennekoon GI. 1995. Purification and expansion of human Schwann cells in vitro. Nat Med 1:80 - 83.
44. Samuel NM, Jessen KR, Grange JM, Mirsky R. 1987. Gamma interferon, but not Mycobacterium leprae, induces major histocompatibility Class II antigens on cultured rat Schwann cells. J Neurocytol 16:281 - 287.
45. Schmidt B, Stoll G, Hartung HP, Heininger K, Schafer B, Toyka KV. 1990. Macrophages but not Schwann cells express Ia antigen in experimental autoimmune neuritis. Ann Neurol 28:70 - 77.
46. Schmidt B, Toyka KV, Kiefer R, Full J, Hartung HP, Pollard J. 1996. Inflammatory infiltrates in sural nerve biopsies in Guillain-Barre syndrome and chronic inflammatory demyelinating neuropathy. Muscle Nerve 19:474 - 487.
47. Spierings E, de Boer T, Wieles B, Adams LB, Marani E, Ottenhoff TH. 2001. Mycobacterium leprae-specific, HLA Class II-restricted killing of human Schwann cells by CD4+ Th1 cells: A novel immunopathogenic mechanism of nerve damage in leprosy. J Immunol 166:5883 - 5888.
48. Stam NJ, Spits H, Ploegh HL. 1986. Monoclonal antibodies raised against denatured HLA-B locus heavy chains permit biochemical characterization of certain HLA-C locus products. J Immunol 137:2299 - 2306.
49. Temponi M, Kekish U, Hamby CV, Nielsen H, Marboe CC, Ferrone S. 1993. Characterization of anti-HLA Class II monoclonal antibody LGII-612.14 reacting with formalin fixed tissues. J Immunol Methods 161:239 - 256.
50. Trombetta ES, Mellman I. 2005. Cell biology of antigen processing in vitro and in vivo. Annu Rev Immunol 23:975 - 1028.
51. Tsai CP, Pollard JD, Armati PJ. 1991. Interferon-gamma inhibition suppresses experimental allergic neuritis: Modulation of major histocompatibility complex expression of Schwann cells in vitro. J Neuroimmunol 31:133 - 145.
52. Tsuyuki Y, Fujimaki H, Hikawa N, Fujita K, Nagata T, Minami M. 1998. IFN-gamma induces coordinate expression of MHC Class I-mediated antigen presentation machinery molecules in adult mouse Schwann cells. Neuroreport 9:2071 - 2075.
53. Van Rhijn I, Van den Berg LH, Bosboom WM, Otten HG, Logtenberg T. 2000. Expression of accessory molecules for T-cell activation in peripheral nerve of patients with CIDP and vasculitic neuropathy. Brain 123:2020 - 2029.
54. Wanschitz J, Maier H, Lassmann H, Budka H, Berger T. 2003. Distinct time pattern of complement activation and cytotoxic T cell response in Guillain-Barre syndrome. Brain 126 (Part 9):2034 - 2042.
55. Weiss S, Bogen B. 1991. MHC Class II-restricted presentation of intracellular antigen. Cell 64:767 - 776.
56. Wekerle H, Schwab M, Linington C, Meyermann R. 1986. Antigen presentation in the peripheral nervous system: Schwann cells present endogenous myelin autoantigens to lymphocytes. Eur J Immunol 16:1551 - 1557.
57. Wang X, Campoli M, Cho HS, Ogino T, Bandoh N, Shen J, Hur SY, Kageshita T, Ferrone S. 2005. A method to generate antigen-specific mAb capable of staining formalin-fixed, paraffin-embedded tissue sections. J Immunol Methods 299:139 - 151.
58. Willison HJ, Yuki N. 2002. Peripheral neuropathies and anti-glycolipid antibodies. Brain 125 (Part 12):2591 - 2625.
59. Yuki N. 2005. Carbohydrate mimicry: A new paradigm of autoimmune diseases. Curr Opin Immunol 17:577 - 582.
60. Yuki N, Susuki K, Koga M, Nishimoto Y, Odaka M, Hirata K, Taguchi K, Miyatake T, Furukawa K, Kobata T, Yamada M. 2004. Carbohydrate mimicry between human ganglioside GM1 and Campylobacter jejuni lipooligosaccharide causes Guillain-Barre syndrome. Proc Natl Acad Sci USA 101:11404 - 11409.
61. Zwadlo G, Schlegel R, Sorg C. 1986. A monoclonal antibody to a subset of human monocytes found only in the peripheral blood and inflammatory tissues. J Immunol 137:512 - 518.